Dubai-headquartered Kelix Bio, wholly owned by Abu Dhabi’s Mubadala Funding (Mubadala), has accomplished the acquisition of insulin producer DiabTec, a subsidiary of Ras Al Khaimah-headquartered Julphar, for an undisclosed charge.
¬ Haymarket Media Restricted. All rights reserved.
👇Observe extra 👇
👉 bdphone.com
👉 ultractivation.com
👉 trainingreferral.com
👉 shaplafood.com
👉 bangladeshi.help
👉 www.forexdhaka.com
👉 uncommunication.com
👉 ultra-sim.com
👉 forexdhaka.com
👉 ultrafxfund.com
👉 bdphoneonline.com
👉 dailyadvice.us